Viromimetic STING agonist‐loaded hollow polymeric nanoparticles for safe and effective vaccination against Middle East respiratory syndrome coronavirus

LCW Lin, CY Huang, BY Yao, JC Lin… - Advanced functional …, 2019 - Wiley Online Library
The continued threat of emerging, highly lethal infectious pathogens such as Middle East
respiratory syndrome coronavirus (MERS‐CoV) calls for the development of novel vaccine …

A novel nanobody targeting Middle East respiratory syndrome coronavirus (MERS-CoV) receptor-binding domain has potent cross-neutralizing activity and protective …

G Zhao, L He, S Sun, H Qiu, W Tai, J Chen, J Li… - Journal of …, 2018 - Am Soc Microbiol
ABSTRACT The newly emerged Middle East respiratory syndrome coronavirus (MERS-
CoV) continues to infect humans and camels, calling for efficient, cost-effective, and broad …

Engineering a self-navigated MnARK nanovaccine for inducing potent protective immunity against novel coronavirus

Y Wang, Y Xie, J Luo, M Guo, X Hu, X Chen, Z Chen… - Nano Today, 2021 - Elsevier
Effective vaccines are vital to fight against the COVID-19 global pandemic. As a critical
component of a subunit vaccine, the adjuvant is responsible for strengthening the antigen …

Development of spike receptor-binding domain nanoparticles as a vaccine candidate against SARS-CoV-2 infection in ferrets

YI Kim, D Kim, KM Yu, HD Seo, SA Lee, MAB Casel… - MBio, 2021 - Am Soc Microbiol
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a causative agent of the
CoV disease 2019 (COVID-19) pandemic, enters host cells via the interaction of its receptor …

Self-assembling nanoparticle vaccines displaying the receptor binding domain of SARS-CoV-2 elicit robust protective immune responses in rhesus monkeys

H Li, L Guo, H Zheng, J Li, X Zhao, J Li… - Bioconjugate …, 2021 - ACS Publications
SARS-CoV-2 caused the COVID-19 pandemic that lasted for more than a year. Globally,
there is an urgent need to use safe and effective vaccines for immunization to achieve …

Rapid development of SARS-CoV-2 spike protein receptor-binding domain self-assembled nanoparticle vaccine candidates

YF Kang, C Sun, Z Zhuang, RY Yuan, Q Zheng, JP Li… - ACS …, 2021 - ACS Publications
The coronavirus disease pandemic of 2019 (COVID-19) caused by the novel SARS-CoV-2
coronavirus resulted in economic losses and threatened human health worldwide. The …

Heterologous prime–boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory …

SY Jung, KW Kang, EY Lee, DW Seo, HL Kim, H Kim… - Vaccine, 2018 - Elsevier
Abstract The Middle East respiratory syndrome coronavirus (MERS-CoV) is a highly
pathogenic and zoonotic virus with a fatality rate in humans of over 35%. Although several …

[HTML][HTML] Nanoparticle vaccines based on the receptor binding domain (RBD) and heptad repeat (HR) of SARS-CoV-2 elicit robust protective immune responses

X Ma, F Zou, F Yu, R Li, Y Yuan, Y Zhang, X Zhang… - Immunity, 2020 - cell.com
Various vaccine strategies have been proposed in response to the global COVID-19
pandemic, each with unique strategies for eliciting immune responses. Here, we developed …

Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization

S Chiba, SJ Frey, PJ Halfmann, M Kuroda… - Communications …, 2021 - nature.com
The COVID-19 pandemic continues to wreak havoc as worldwide SARS-CoV-2 infection,
hospitalization, and death rates climb unabated. Effective vaccines remain the most …

A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross‐Protection Activity against Multiple SARS‐CoV‐2 Sublineages

X Zhang, S Wu, J Liu, R Chen, Y Zhang, Y Lin… - Advanced …, 2023 - Wiley Online Library
Because of the rapid mutation and high airborne transmission of SARS‐CoV‐2, a universal
vaccine preventing the infection in the upper respiratory tract is particularly urgent. Here, a …